Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL

AIM: Targeted therapies have substantially improved the survival of patients with metastatic clear cell renal cell cancer. No prognostic or predictive biomarkers are available. Comprehensive genetic profiling offers the opportunity to define prognostic and predictive signatures aiming at a more pers...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Future Sci OA
Autori principali: Dieffenbacher, Svenja, Zschäbitz, Stefanie, Hofer, Luisa, Hatiboglu, Gencay, Hou, Weibin, Hohenfellner, Markus, Duensing, Stefan, Sültmann, Holger, Pahernik, Sascha, Grüllich, Carsten
Natura: Artigo
Lingua:Inglês
Pubblicazione: Future Science Ltd 2018
Soggetti:
Clinical Trial Protocol
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5961447/
https://ncbi.nlm.nih.gov/pubmed/29796302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fsoa-2017-0150
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi